XGN - Exagen teams up with Tufts Medical Center for its AVISE tests

Exagen (XGN) announces that all of its AVISE test offerings are now a contracted in-network service with Tufts Medical Center, an internationally-respected academic medical center."The incorporation of AVISE testing will play an important part in enabling rheumatologists’ ability to improve patient care through the differential diagnosis, prognosis, and monitoring of complex autoimmune diseases," CEO Ron Rocca said.Exagen has developed and is commercializing a portfolio of innovative testing products under its AVISE brand, while Tufts Medical Center is recognized as one of the nation’s leading centers for the treatment of arthritis and rheumatic disease.

For further details see:

Exagen teams up with Tufts Medical Center for its AVISE tests